GPN Vaccines is a public (unlisted) biotechnology company developing a vaccine against Streptococcus pneumoniae
, which is responsible for causing life-threatening pneumonia, bacteraemia and meningitis, as well as otitis media (middle ear infections). Each year it causes 1-2 million deaths worldwide, killing more children than AIDS, malaria and tuberculosis combined. There are now 100 different serotypes of S. pneumoniae and the best vaccine currently on the market only protects against 20 of them. Gamma-PN – GPN Vaccines’ new S. pneumoniae
vaccine is being developed to protect children and adults against all S. pneumoniae strains
, regardless of strain serotype.